Workflow
思泰瑞(STE)
icon
搜索文档
STERIS(STE) - 2025 Q2 - Quarterly Results
2024-11-07 05:45
财务业绩 - 总收入同比增长7%,以恒定汇率计算的有机收入增长7%[1] - 报告期内每股收益为1.51美元,调整后每股收益为2.14美元[2] - 公司维持2025财年全年业绩指引[1] - 公司三个季度的总收入分别为13.29亿美元、12.38亿美元和26.08亿美元[17] - 公司三个季度的毛利润分别为5.79亿美元、5.46亿美元和11.51亿美元[17] - 公司三个季度的营业利润分别为2.20亿美元、1.92亿美元和4.05亿美元[17] - 公司三个季度的净利润分别为1.50亿美元、1.15亿美元和2.95亿美元[17] - 公司三个季度的每股收益(基本)分别为1.52美元、1.17美元和2.99美元[17] - 公司三个季度的每股收益(稀释)分别为1.51美元、1.16美元和2.98美元[17] - 公司在2024财年上半年实现营业收入26.08亿美元,同比增长7.7%[26] - 公司在2024财年上半年实现经调整后每股收益2.14美元,同比增长15.1%[28] - 公司在2024财年上半年实现自由现金流3.44亿美元,同比增长21.0%[22] - 公司在2024财年第三季度实现营业收入13.29亿美元,同比增长7.3%[25] - 公司在2024财年第三季度实现经调整后每股收益2.14美元,同比增长15.1%[28] - 公司在2024财年第三季度实现经调整后净利润2.13亿美元,同比增长5.0%[27] - 公司总收入同比增长7.3%,达到13.29亿美元[32] - 经常性收入同比增长10.7%,达到10.47亿美元[32] - 预计2025财年全年调整后每股收益在9.05美元至9.25美元之间[31] - 预计2025财年经营活动现金流为10.6亿美元,资本支出为3.6亿美元,自由现金流为7亿美元[31] - 公司整体调整后税率为22.7%[32] 业务表现 - 医疗保健业务收入同比增长9%,其中耗材收入增长12%、服务收入增长14%、资本设备收入下降2%[3] - 应用灭菌技术业务收入同比增长9%,其中服务收入增长6%、资本设备收入大幅增加[4] - 生命科学业务收入同比下降4%,主要由于4月1日剥离CECS业务(主要为服务收入)[5] - 公司在2024财年上半年实现医疗保健业务收入18.45亿美元,同比增长9.3%[26] - 公司在2024财年上半年实现生命科学业务收入2.56亿美元,同比下降3.1%[26] - 公司在2024财年第三季度实现医疗保健业务收入9.44亿美元,同比增长8.5%[25] - 医疗保健分部收入同比增长8.5%,达到9.44亿美元[32] - 生命科学分部收入同比下降3.9%,达到1.28亿美元[32] - 医疗保健分部营业利润同比增长11.7%,达到2.28亿美元[32] - 生命科学分部营业利润同比增长6.8%,达到5370万美元[32] - 公司整体美国市场收入占比73%[32] 现金流与资产负债 - 上半年经营活动产生的现金流为5.545亿美元,自由现金流为3.445亿美元[6] - 公司三个季度的现金及现金等价物分别为1.72亿美元、2.07亿美元[18] - 公司三个季度的总资产分别为102.42亿美元、110.64亿美元[18] - 公司三个季度的总负债分别为36.32亿美元、44.84亿美元[18] - 公司三个季度的总权益分别为66.10亿美元、63.15亿美元[18]
STERIS Announces Financial Results for Fiscal 2025 Second Quarter
GlobeNewswire News Room· 2024-11-07 05:30
Total revenue from continuing operations increased 7%; constant currency organic revenue grew 7%As reported diluted EPS from continuing operations increased to $1.51; adjusted EPS increased to $2.14Fiscal 2025 outlook reiterated DUBLIN, IRELAND, Nov. 06, 2024 (GLOBE NEWSWIRE) --  - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 second quarter ended September 30, 2024. Total revenue from continuing operations for the second quarter of fiscal 2025 inc ...
Steris (STE) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
ZACKS· 2024-11-01 22:20
Wall Street analysts expect Steris (STE) to post quarterly earnings of $2.11 per share in its upcoming report, which indicates a year-over-year increase of 3.9%. Revenues are expected to be $1.34 billion, down 0.4% from the year-ago quarter.Over the last 30 days, there has been a downward revision of 1.3% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Ah ...
STERIS Declares Dividend of $0.57 per share
GlobeNewswire News Room· 2024-10-31 04:30
DUBLIN, IRELAND, Oct. 30, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on December 19, 2024, to shareholders of record at the close of business on November 19, 2024.   Additional information about the U.S. tax treatment of dividends, including required Forms 8937, is available at www.steris-ir.com. STERIS is a leading global provider of products and service ...
STERIS to Host a Conference Call for Fiscal 2025 Second Quarter Financial Results on November 7, 2024
GlobeNewswire News Room· 2024-10-24 04:30
DUBLIN, IRELAND, Oct. 23, 2024 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 second quarter financial results at 9:00 a.m. ET on November 7, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.   A press release detailing financial results will ...
STE Gears Up for Q2 Earnings: Here's What You Need to Know
ZACKS· 2024-10-21 22:10
文章核心观点 - STERIS plc (STE)即将发布2025财年第二季度业绩 [1] - 公司上一季度的调整每股收益(EPS)为2.03美元,超出市场预期1% [1] - 公司过去4个季度中有3个季度的业绩超出预期 [1] 财务数据总结 收入 - 公司第二季度的预计收入为13.4亿美元,同比下降0.4% [2] 每股收益 - 公司第二季度的预计每股收益为2.12美元,同比增长4.4% [2] 业绩预期 - 过去30天内,公司第二季度的每股收益预期保持不变,为2.12美元 [3] 业务板块分析 医疗保健(Healthcare) - 上一季度,耗材和服务业务增长强劲,受益于美国的手术量增加以及价格和市场份额的提升,预计该趋势在第二季度将持续 [4] - 公司的医疗保健业务积压订单预计在第二季度已经得到缓解,公司专注于缩短交货周期以满足客户需求 [4] - 上一季度,医疗保健资本设备收入在宏观环境挑战下有所下降,但公司预计全年将实现低个位数的收入增长,且经常性收入将继续高于手术量增长,相对独立于资本设备出货量 [4][5] 应用消毒技术(AST) - 上一季度,AST业务实现有机收入增长,表现是公司过去一年中最好的,欧洲医疗技术业务也实现良好增长,生物加工业务则持平 [6] - 公司预计生物加工业务将在2025财年下半年恢复增长 [6] - 预计AST业务第二季度收入将同比增长5.4% [6] 生命科学(Life Sciences) - 上一季度,该业务收入受到已剥离的受控环境服务(CECS)业务的影响,但在消耗品业务的带动下实现了恒定汇率下的有机增长,预计该趋势将在第二季度持续 [6][7] - 预计生命科学业务第二季度收入将同比增长3.9% [7]
Steris (STE) Up 3% Since Last Earnings Report: Can It Continue?
ZACKS· 2024-09-06 00:35
A month has gone by since the last earnings report for Steris (STE) . Shares have added about 3% in that time frame, underperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Steris due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. STERIS Q1 Earnings Beat Estimates, Operating Margin Falls STERI ...
Reasons to Retain STERIS Stock in Your Portfolio for Now
ZACKS· 2024-09-04 21:35
STERIS plc (STE) rides on the robust performance of its Healthcare business.The company also benefits from the strong rebound prospects for its Applied Sterilization Technologies ("AST") segment. Meanwhile, headwinds such as foreign currency risks and macroeconomic challenges are concerning. Year to date, shares of this Zacks Rank #3 (Hold) company have risen 10.6% compared with the industry's 10% growth and the S&P 500's 18.4% increase. The renowned provider of infection prevention and other procedural pro ...
STERIS to Present at the Morgan Stanley Healthcare Conference
GlobeNewswire News Room· 2024-08-27 04:30
DUBLIN, IRELAND, Aug. 26, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced today that it will participate in the Morgan Stanley Healthcare Conference in New York City on Wednesday, September 4, 2024. Dan Carestio, President and CEO of STERIS will present at 1:50 p.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on STERIS's investor relations website at www.steris-ir.com. STERIS is a leading global provider of products an ...
Steris: Q2 Numbers Solidify Buy Thesis
Seeking Alpha· 2024-08-13 21:51
I I F ■ F Matteo Colombo Investment update Following my last publication on STERIS plc (NYSE:STE) the stock is +2.5% in the green after backing and filling into congestion. The company's Q1 FY'25 numbers gleaned several insights that provide a comprehensive view into what to expect for the remainder of the financial year. That report, titled "Remains on track for strong fiscal 24", outlined several bullish factors in the debate, including: STE staged an upside move off lows in early '23, where I advocated b ...